Press release
Vertex to Present at Cowen’s 42nd Annual Health Care Conference on March 8
BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at Cowen’s 42nd Annual Health Care
About this update from Vertex Pharmaceuticals Incorporated
[{"type":"text","content":" BOSTON--(BUSINESS WIRE)--\nVertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at Cowen’s 42nd Annual Health Care Conference on Tuesday, March 8, 2022 at 2:50 p.m. ET.\n\nA live webcast of management's remarks will be available through Vertex's website, www.vrtx.com in the \"Investors\" section under the \"News and Events\" page. A replay of the conference webcast will be archived on the company's website.\n\nAbout Vertex\n\nVertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule, cell and genetic therapies in other serious diseases where it has deep insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes, alpha-1 antitrypsin deficiency and Duchenne muscular dystrophy.\n\nFounded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 12 consecutive years on Science magazine's Top Employers list and one of the 2021 Seramount (formerly Working Mother Media) 100 Best Companies. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.\n\n(VRTX-WEB)\nView source version on businesswire.com: https://www.businesswire.com/news/home/20220301006167/en/\n\nVertex Pharmaceuticals Incorporated Investors:\nMichael Partridge, 617-341-6108\nManisha Pai, 617-429-6891\nMiroslava Minkova, 617-341-6135\n\nSource: Vertex Pharmaceuticals Incorporated","length":4673,"tagName":"div"}]